Akari Therapeutics Plc Cash and Equivalents
Quick Answer Akari Therapeutics Plc reported Cash and Equivalents of $2.60 million for fiscal year 2024. Akari Therapeutics Plc Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2024 $2.60M -32.4% 2023 $3.85M -71.0% 2022 $13.25M +41.5% 2021 $9.36M -33.4% 2020 $14.06M +14.1% 2020 $12.32M -3.4% 2020 $12.75M +63.0% 2020 $7.82M … Read more